Argent BioPharma Limited (RGT.L)

GBp 6.0

(-7.69%)

Net Income Summary of Argent BioPharma Limited

Argent BioPharma Limited's latest annual net income in 2023 was -17.53 Million AUD , down -60.45% from previous year.
Argent BioPharma Limited's latest quarterly net income in 2023 Q4 was -3.78 Million GBP , up 27.45% from previous quarter.
Argent BioPharma Limited reported an annual net income of -10.92 Million AUD in 2022, up 5.28% from previous year.
Argent BioPharma Limited reported an annual net income of -11.53 Million AUD in 2021, down -33.75% from previous year.
Argent BioPharma Limited reported a quarterly net income of -5.21 Million GBP for 2023 Q2, up 14.92% from previous quarter.
Argent BioPharma Limited reported a quarterly net income of -10.92 Million AUD for 2022 FY, up 5.28% from previous quarter.

Annual Net Income Chart of Argent BioPharma Limited (2023 - 2015)

Historical Annual Net Income of Argent BioPharma Limited (2023 - 2015)

Year	Net Income	Net Income Growth
2023	-17.53 Million AUD	-60.45%
2022	-10.92 Million AUD	5.28%
2021	-11.53 Million AUD	-33.75%
2020	-8.62 Million AUD	20.07%
2019	-10.78 Million AUD	-128.08%
2018	-4.73 Million GBP	-2.51%
2017	-4.61 Million GBP	4.04%
2016	-4.8 Million GBP	-40.23%
2015	-3.42 Million GBP	0.0%

Year	Net Income	Net Income Growth
2023 Q4	-3.78 Million GBP	27.45%
2023 Q2	-5.21 Million GBP	14.92%
2022 FY	-10.92 Million AUD	5.28%
2022 Q4	-6.13 Million GBP	16.22%
2022 Q2	-7.31 Million GBP	-72.94%
2021 Q2	-5.25 Million GBP	-50.16%
2021 FY	-11.53 Million AUD	-33.75%
2021 Q4	-4.23 Million GBP	19.48%
2020 Q4	-3.49 Million GBP	16.87%
2020 FY	-8.62 Million AUD	20.07%
2020 Q2	-4.2 Million GBP	32.81%
2019 FY	-10.78 Million AUD	-128.08%
2019 Q4	-6.26 Million GBP	0.0%
2018 FY	-4.73 Million GBP	-2.51%
2017 FY	-4.61 Million GBP	4.04%
2016 FY	-4.8 Million GBP	-40.23%
2015 FY	-3.42 Million GBP	0.0%

Peer Net Income Comparison of Argent BioPharma Limited

Name	Net Income	Net Income Difference